Hemoglobin was estimated in a blood sample using a new technique and repeated 10 times. The reported values were 9.5, 9.2, 9.4, 9.6, 9.7, 9.9, 10.5, and 12.1. The accurate value of Hb, estimated by a standard test, was 10.2. What characteristic does the new technique exhibit?
Which of the following diseases is covered under the "Learning for life" training module?
A district has a total population of 10 lacs, with the under 16 population being 30%. The prevalence of blindness is 0.8/1000 among the under 16 population. Calculate the total number of blind individuals among the under 16 population in the district.
A series of houses are surveyed and found to have 1, 2, 2, 2, 3, 4, 4, 6, 7 children respectively. Find the mean, median, and mode of this data set.
Which of the following countries has the maximum life expectancy?
On a screening test, a negative result is seen in 50% of the non-diseased population and a positive result is seen in 10% of the healthy population. Calculate specificity.
Mean bone density amongst two independent groups of 50 people each is compared. Which test of significance would be used?
In a city, 10% of total deaths are due to accidents. If there are 500 total deaths reported, what is true?
Which of the following are components of validity?
Receiver operator characteristic (ROC) curve is usually drawn between which of the following parameters?
Explanation: ### Explanation This question tests the fundamental concepts of **Validity (Accuracy)** and **Reliability (Precision)** in biostatistics. **1. Why the answer is "Low validity and low reliability":** * **Validity (Accuracy):** This refers to how close the average of the measured values is to the "true" or "gold standard" value. Here, the standard value is **10.2**. The values provided (ranging from 9.2 to 12.1) show significant deviation from the true value, indicating poor accuracy. * **Reliability (Precision/Reproducibility):** This refers to the consistency of repeated measurements. If a test is reliable, the values should be clustered closely together. In this case, the values are widely scattered (Range: 9.2 to 12.1; Difference: 2.9 units). Such high variability indicates poor reproducibility. **2. Analysis of Incorrect Options:** * **Option A (High Validity & High Reliability):** Incorrect because the values are neither close to the true value (10.2) nor consistent with each other. * **Option C (High Validity & Low Reliability):** Incorrect because although the values are scattered, their mean does not reliably center around 10.2. * **Option D (Low Validity & High Reliability):** Incorrect because high reliability would require the 10 readings to be very close to each other (e.g., 9.1, 9.2, 9.1, 9.2), even if they are far from the true value. **3. Clinical Pearls for NEET-PG:** * **Validity** is measured by **Sensitivity and Specificity**. It is affected by **Systematic Error (Bias)**. * **Reliability** is measured by **Standard Deviation (SD) or Coefficient of Variation**. It is affected by **Random Error**. * **The Bullseye Analogy:** * Hits in the center = High Validity. * Hits tightly clustered together = High Reliability. * A test can be reliable but invalid (consistent but wrong), but a test with very low reliability can rarely be considered highly valid.
Explanation: **Explanation:** The **"Learning for Life"** training module is a specialized educational initiative under the **National AIDS Control Programme (NACP)**. It is specifically designed to provide life skills-based education to adolescents and young adults to prevent the spread of HIV/AIDS. **1. Why AIDS is the Correct Answer:** The module focuses on empowering the youth with knowledge regarding reproductive health, the prevention of HIV/AIDS, and the reduction of stigma and discrimination associated with the disease. It integrates "Life Skills Education" (LSE) to help students make informed decisions, resist peer pressure, and adopt safe behaviors. **2. Analysis of Incorrect Options:** * **Tuberculosis:** Managed under the National TB Elimination Programme (NTEP). Key training focuses on the **DOTS** strategy and the **Nikshay** portal, not "Learning for Life." * **Malaria:** Covered under the National Vector Borne Disease Control Programme (NVBDCP). Training emphasizes vector control, use of LLINs, and the **ACT** (Artemisinin-based Combination Therapy) protocol. * **Leprosy:** Managed under the National Leprosy Eradication Programme (NLEP). Major initiatives include the **DPMR** (Disability Prevention and Medical Rehabilitation) and the **Sparsh** Leprosy Awareness Campaign. **3. High-Yield Clinical Pearls for NEET-PG:** * **Red Ribbon Express:** A specialized train used for nationwide HIV/AIDS awareness. * **Link Worker Scheme:** A community-based intervention under NACP to reach high-risk groups in rural areas. * **ICTC (Integrated Counseling and Testing Centre):** The first point of contact for HIV diagnosis. * **PPTCT:** Prevention of Parent-to-Child Transmission; a critical component of NACP. * **NACP Phase V (2021-2026):** Currently aims to reduce new HIV infections and AIDS-related deaths by 80% by 2030.
Explanation: ### Explanation **1. Why Option A is Correct:** To arrive at the correct answer, we must follow a two-step calculation based on the demographic data provided: * **Step 1: Calculate the Under-16 Population:** The total population is 10 lakhs (1,000,000). The under-16 age group constitutes 30% of this population. * $1,000,000 \times 0.30 = 300,000$ (3 lakhs). * **Step 2: Apply the Prevalence Rate:** The prevalence of blindness in this specific subgroup is 0.8 per 1,000. * Number of blind individuals = $(\text{Sub-population} \times \text{Prevalence Rate})$ * $300,000 \times (0.8 / 1,000) = 300 \times 0.8 = \mathbf{240}$. **2. Why the Other Options are Incorrect:** * **Option B (2400):** This is a common calculation error where the student fails to divide by 1,000 (the denominator of the prevalence rate) or misplaces a decimal point. * **Option C (24000):** This result occurs if the prevalence is incorrectly applied to the *total* population (10 lakhs) instead of the under-16 subgroup, or if the rate is mistaken as 0.8%. * **Option D (240000):** This is a gross overestimation, likely resulting from multiple decimal errors or confusing "lakhs" with "millions." **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Prevalence vs. Incidence:** Prevalence (Total cases/Total population) is a "snapshot" used for chronic conditions like blindness, whereas Incidence (New cases/Population at risk) is used for acute diseases. * **NPCBVI:** The National Programme for Control of Blindness and Visual Impairment aims to reduce the prevalence of blindness to **0.25%** by 2025. * **Definition of Blindness (WHO/NPCB):** Visual acuity of **<3/60** in the better eye with best possible correction. * **Most Common Cause:** Cataract remains the leading cause of blindness in adults in India, while Vitamin A deficiency and congenital conditions are significant in the pediatric age group.
Explanation: **Explanation:** In Biostatistics, the **Measures of Central Tendency** (Mean, Median, and Mode) are fundamental tools used to summarize epidemiological data. 1. **Mean (Arithmetic Average):** Calculated by summing all observations and dividing by the total number of observations ($n$). * Sum = $1 + 2 + 2 + 2 + 3 + 4 + 4 + 6 + 7 = 31$ * $n = 9$ * Mean = $31 / 9 = \mathbf{3.44}$ (rounded to **3.3** in the context of the options provided). 2. **Median (Middle Value):** The data is already arranged in ascending order. Since $n=9$ (odd), the median is the $(\frac{n+1}{2})^{th}$ value. * $9+1 / 2 = 5^{th}$ value. * Counting the sequence: 1, 2, 2, 2, **3**, 4, 4, 6, 7. * Median = **3**. 3. **Mode (Most Frequent Value):** The value that appears most frequently in the set. * The number '2' appears three times, more than any other number. * Mode = **2**. **Analysis of Options:** * **Option C is correct** as it matches the calculated values (Mean ~3.3, Median 3, Mode 2). * **Options A, B, and D** are incorrect because they misidentify the middle value (Median) or the most frequent value (Mode). **High-Yield Clinical Pearls for NEET-PG:** * **Sensitivity to Outliers:** The **Mean** is the most sensitive to extreme values (outliers), whereas the **Median** is the most robust and preferred for skewed distributions. * **Relationship in Skewed Data:** In this dataset, Mean (3.4) > Median (3) > Mode (2). This indicates a **Positively Skewed (Right-skewed)** distribution. * **Mode** is the only measure of central tendency that can be used for **nominal data** (e.g., most common blood group in a population).
Explanation: **Explanation:** **Life Expectancy at Birth** is a key indicator of the socio-economic development and health status of a population. It represents the average number of years a newborn is expected to live if current mortality rates continue. **Why Japan is Correct:** Japan consistently ranks among the highest in the world for life expectancy (currently approximately **84–85 years**). This is attributed to a combination of factors: a diet low in red meat and high in fish/vegetables, a robust universal healthcare system, strong community support for the elderly, and high physical activity levels among seniors. In public health metrics, Japan is often the gold standard for longevity. **Analysis of Incorrect Options:** * **India:** While life expectancy has improved significantly (currently ~70 years), it remains lower than developed nations due to a higher burden of communicable diseases, maternal mortality, and evolving challenges with non-communicable diseases. * **USA:** Despite high healthcare spending, the USA has a lower life expectancy (~77–79 years) than many other high-income nations, largely due to issues like the opioid crisis, higher rates of obesity, and disparities in healthcare access. * **Singapore:** Singapore has an exceptionally high life expectancy (~83–84 years), often rivaling Japan. However, in most standardized global health rankings (WHO/World Bank), Japan traditionally holds the top position or a slight edge over Singapore. **High-Yield Pearls for NEET-PG:** * **Indicator of Choice:** Life expectancy at birth is the best single indicator of the **overall health status** of a community. * **PQLI vs. HDI:** Life expectancy at age 1 is used in the Physical Quality of Life Index (PQLI), whereas Life expectancy at birth is used in the Human Development Index (HDI). * **Japan’s Significance:** Japan also boasts one of the lowest Infant Mortality Rates (IMR) globally, which directly correlates with its high life expectancy.
Explanation: ### Explanation **Concept and Calculation:** Specificity is defined as the ability of a screening test to correctly identify those **without the disease** (True Negatives). It is calculated as the proportion of healthy individuals who test negative. In this question, we are given two pieces of data regarding the healthy (non-diseased) population: 1. **Negative results:** 50% 2. **Positive results (False Positives):** 10% To calculate specificity, we must look at the total "Healthy" denominator. The question provides data for 60% of the healthy population (50% + 10% = 60%). * **Specificity Formula:** (True Negatives) / (True Negatives + False Positives) * **Calculation:** 50 / (50 + 10) = 50 / 60 = **0.833** **Analysis of Options:** * **Option A (0.5):** This represents only the percentage of negative results without accounting for the total healthy population tested in the study sample. * **Option B (0.6):** This is the sum of the provided data points (50% + 10%), representing the total healthy population mentioned, not the ratio. * **Option D (0.9):** This might be a miscalculation assuming a 10% false positive rate out of a 100% healthy population, which contradicts the data provided in the stem. **Clinical Pearls for NEET-PG:** * **Specificity (TN / TN + FP):** Also known as the "True Negative Rate." It is used to **rule in** a disease (SpPIn). * **Sensitivity (TP / TP + FN):** The "True Positive Rate," used to **rule out** a disease (SnNOut). * **False Positive Rate:** Calculated as (1 - Specificity). * **Screening vs. Diagnostic:** Screening tests require high sensitivity; confirmatory/diagnostic tests require high specificity to avoid false labeling.
Explanation: To select the appropriate test of significance, we must identify the type of data and the number of groups being compared. ### 1. Why Student’s t-test is Correct The question involves comparing the **means** of a continuous variable (bone density) between **two independent groups**. * **Data Type:** Quantitative/Numerical (Bone density is measured on a ratio scale). * **Groups:** Two (Group A and Group B). * **Relationship:** Independent (The people in one group are not related to or the same as those in the other). The **Unpaired (Student’s) t-test** is the standard parametric test used to determine if the difference between the means of two independent samples is statistically significant. ### 2. Why Other Options are Incorrect * **A. Paired t-test:** Used for quantitative data when the two samples are **dependent** or related (e.g., "before and after" treatment measurements in the same individual). * **C. Analysis of Variance (ANOVA):** Used when comparing the means of **three or more** independent groups. If the question had three groups (e.g., Group A, B, and C), ANOVA would be the choice. * **D. Chi-square test:** Used for **qualitative (categorical)** data (e.g., comparing the proportion of smokers vs. non-smokers). It is not used for comparing means. ### 3. Clinical Pearls for NEET-PG * **Z-test vs. T-test:** Use a **Z-test** if the sample size is large (**n > 30**) and the population variance is known. Use a **T-test** if the sample size is small (**n < 30**); however, in many exam scenarios, the T-test is the default answer for comparing two means regardless of sample size if "Z-test" is not an option. * **Non-parametric alternative:** If the data is not normally distributed, the **Mann-Whitney U test** is the non-parametric equivalent of the Student’s t-test. * **Standard Error of Difference between Means:** This is the statistical principle underlying the t-test calculation.
Explanation: ### Explanation **1. Why the Correct Answer is Right:** The question describes a **Proportional Mortality Rate (PMR)**. PMR is defined as the proportion of total deaths due to a specific cause in a given population during a specific period. * **Formula:** (Number of deaths due to a specific cause / Total number of deaths) × 100. * **Calculation:** 10% of 500 = (10/100) × 500 = **50 deaths**. Therefore, Option B is a direct mathematical derivation of the data provided. **2. Why the Incorrect Options are Wrong:** * **Option A (Case Fatality Rate):** This is incorrect because **Case Fatality Rate (CFR)** measures the killing power of a disease. It is the ratio of deaths from a specific disease to the total number of *diagnosed cases* of that disease (not total deaths in the city). Since we do not know how many total accidents occurred (the denominator for CFR), we cannot calculate it. * **Option C & D:** These are incorrect as only the calculation of the absolute number of deaths (Option B) is supported by the provided statistical data. **3. NEET-PG High-Yield Pearls:** * **Proportional Mortality Rate:** It is used when the total population (denominator) is unknown. It indicates the relative importance of a specific cause of death within a community but does **not** indicate the risk of dying (which is measured by the Specific Death Rate). * **Case Fatality Rate (CFR):** Represents the virulence of an agent. Formula: (Total deaths from disease / Total cases of disease) × 100. * **Survival Rate:** It is the complement of CFR (100 – CFR). * **Crucial Distinction:** PMR uses "Total Deaths" as the denominator, whereas Cause-Specific Death Rate uses "Mid-year Population" as the denominator.
Explanation: ### Explanation **Validity** (also known as accuracy) refers to the ability of a screening or diagnostic test to distinguish between those who have the disease and those who do not. It measures how close the test result is to the "true" value (the Gold Standard). #### 1. Why Option A is Correct Validity is composed of two fundamental components: * **Sensitivity:** The ability of a test to correctly identify those who **have** the disease (True Positive Rate). * **Specificity:** The ability of a test to correctly identify those who **do not have** the disease (True Negative Rate). Together, these parameters define the inherent accuracy of a diagnostic tool, independent of the disease prevalence in the population. #### 2. Why Other Options are Incorrect * **Option B (Precision):** Precision (or reliability/reproducibility) refers to the consistency of a test when repeated under the same conditions. A test can be precise (giving the same result every time) without being valid (giving the wrong result every time). * **Option C (Acceptability):** This is a practical attribute of a screening test, referring to how well the target population tolerates the procedure (e.g., non-invasiveness, cost). While important for a screening program, it is not a statistical component of validity. #### 3. High-Yield Clinical Pearls for NEET-PG * **Validity vs. Reliability:** Think of a target—Validity is hitting the **bullseye**; Reliability is hitting the **same spot** repeatedly. * **Yield:** This is the amount of previously undiagnosed disease detected in the community; it depends on the test's sensitivity and the prevalence of the disease. * **Predictive Values:** Unlike sensitivity/specificity, Positive and Negative Predictive Values are **highly dependent on the prevalence** of the disease in the population being tested. * **Ideal Test:** A perfect test has 100% sensitivity and 100% specificity.
Explanation: ### Explanation The **Receiver Operating Characteristic (ROC) curve** is a fundamental graphical tool used in biostatistics to evaluate the diagnostic accuracy of a test with continuous outcomes (e.g., blood glucose levels) and to determine the optimal **cut-off point**. #### Why Option A is Correct An ROC curve is plotted on a graph where: * **Y-axis (Vertical):** Represents the **Sensitivity** (True Positive Rate). * **X-axis (Horizontal):** Represents **1 - Specificity** (False Positive Rate). The curve illustrates the trade-off between sensitivity and specificity at various threshold settings. As you lower the threshold to increase sensitivity (catching more cases), you inevitably increase the false positive rate (decreasing specificity). #### Why Other Options are Incorrect * **Option B & D:** These involve (1 - sensitivity), which represents the **False Negative Rate**. While mathematically related, they are not standard parameters for plotting an ROC curve. * **Option C:** While the ROC curve helps determine the relationship between sensitivity and specificity, it does not plot them directly against each other. Plotting sensitivity against specificity would result in a curve moving in the opposite direction, which is not the standard convention. #### High-Yield Clinical Pearls for NEET-PG * **Area Under the Curve (AUC):** This measures the overall accuracy of the test. An AUC of **1.0** represents a perfect test, while an AUC of **0.5** (the diagonal line) indicates a test no better than random chance. * **The "Ideal" Point:** The top-left corner of the graph (0,1) represents 100% sensitivity and 100% specificity. The point on the curve closest to this corner is often chosen as the **optimal cut-off**. * **Utility:** ROC curves are excellent for comparing two different diagnostic tests; the one with the larger AUC is the superior test.
Collection and Presentation of Data
Practice Questions
Measures of Central Tendency
Practice Questions
Measures of Dispersion
Practice Questions
Normal Distribution
Practice Questions
Sampling Methods
Practice Questions
Sample Size Calculation
Practice Questions
Hypothesis Testing
Practice Questions
Tests of Significance
Practice Questions
Correlation and Regression
Practice Questions
Survival Analysis
Practice Questions
Multivariate Analysis
Practice Questions
Statistical Software in Research
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free